SavedAdd your journal

Journals / Journal of Neurological Sciences (Turkish) / 2012 / Cilt: 29 - Sayı: 3

Bağımlılarda Madde Kullanımı, Yoksunluğu ve Arınma Sürecinde Başağrısı Özellikleri

Headache Characteristics in Addicts During Substance Abuse, Withdrawal and Rehabilitation

Yavuz ALTUNKAYNAK
Belgin MUTLUAY
Burcu POLAT
Refhan BALKAN ÖZTÜRK
Sevim BAYBAS
Duran CAKMAK
Aynur OZGE
Musa OZTURK
Pages
494–502
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mostfrequent substance abused headache was related to cannabis (9.3%), it's followed by heroineand multiple substances (4.3%).Conclusion: It was concluded that primary headache disorders are an important comorbidityof substance abusers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: We organized this prospective clinical based multidisciplinary study in order todetermine clinical headache types and clinical determinants of headache disorders induced bysubstance abuse in relation to phases of substance abuse (abuse, abstinence andrehabilitation).Method: The study consisted of 460 consecutive patients who were diagnosed as addicts andwere treated as inpatient and/or outpatients at AMATEM.
📊
Key Findings & Data:Headache diagnosis has been made by aheadache specialist according to ICHD-II.Results: In total, 296 subjects (64.3%) reported recurrent headaches in all study phases.Patients were diagnosed as tension type headache (TTH) (45.0%), migraine (16.5%) likeheadache disorders, and secondary headache disorders (2.8%), respectively.
💡
Conclusion & Impact:The mostfrequent substance abused headache was related to cannabis (9.3%), it's followed by heroineand multiple substances (4.3%).Conclusion: It was concluded that primary headache disorders are an important comorbidityof substance abusers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: We organized this prospective clinical based multidisciplinary study in order todetermine clinical headache types and clinical determinants of headache disorders induced bysubstance abuse in relation to phases of substance abuse (abuse, abstinence andrehabilitation).Method: The study consisted of 460 consecutive patients who were diagnosed as addicts andwere treated as inpatient and/or outpatients at AMATEM. Patients were assessed in threegroups: Group I; Psycho stimulant users, Group II; Psycho depressant users and Group IIIMultiple substance abusers. They were examined during substance abuse (Phase I),withdrawal (Phase II) and rehabilitation (Phase III). Headache diagnosis has been made by aheadache specialist according to ICHD-II.Results: In total, 296 subjects (64.3%) reported recurrent headaches in all study phases.Patients were diagnosed as tension type headache (TTH) (45.0%), migraine (16.5%) likeheadache disorders, and secondary headache disorders (2.8%), respectively. The mostfrequent substance abused headache was related to cannabis (9.3%), it's followed by heroineand multiple substances (4.3%).Conclusion: It was concluded that primary headache disorders are an important comorbidityof substance abusers. More information has to need about headache triggered by substanceaddiction.

Özet

Amaç: Klinik tabanlı prospektif ve çok disiplinli olarak tasarlanan bu çalışmayı maddebağımlılığı olan bireylerde kullanılan madde tipi ve bağımlılık periyoduna (madde kullanımı,yoksunluk, arınma) bağlı olarak görülen başağrısı türlerini ve özelliklerini belirlemekamacıyla yapıldı.Yöntem: Çalışma grubu AMATEM'de yataklı veya ayaktan takip ünitelerinde takip edilen460 ardışık hastadan oluşuyordu. Hastalar 3 gruba ayrıldı; Grup I; Psiko-stimülan kullananlar,Grup II; Psiko-depresan kullananlar ve Grup III; Çoklu madde kullananlar. Bireyler maddekullandıkları dönem (Faz 1), yoksunluk dönemi (Faz 2) ve arınma döneminde (Faz 3)muayene edilerek sonuçlar kaydedildi. Başağrısı tanısı uzman tarafından ICHD-II ölçütlerigözetilerek konuldu.Bulgular: Toplamda 296 bireyde (%64.3) başağrısı rapor edildi. Ağrı türlerine göresıralandığında sırasıyla gerilim tipi başağrısı (%45.0), migren (%16.5) benzeri başağrısı veikincil başağrıları (%2.8) tanıları konuldu. En sık başağrısı nedeni olarak hint keneviri (%9.3),eroin ve çoklu madde kullanımı (%4.3) rapor edildi.Sonuç: Madde bağımlılığı olan bireylerde başağrısı, özellikle de primer başağrıları önemli birkomorbid durumdur. Madde bağımlılığı ile tetiklenen başağrıları hakkında daha fazla bilgiyeihtiyaç duyulmaktadır.

🔖

Cite This Article

ALTUNKAYNAK, Y., MUTLUAY, B., POLAT, B., ÖZTÜRK, R. B., BAYBAS, S., CAKMAK, D., OZGE, A., OZTURK, M. (2022). Bağımlılarda Madde Kullanımı, Yoksunluğu ve Arınma Sürecinde Başağrısı Özellikleri. Journal of Neurological Sciences (Turkish), Cilt: 29 - Sayı: 3, 494–502. https://ajindex.com/articles/565215

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Auer J, Berent R, Weber T, Lassnig E, Eber B. Subarachnoid haemorrhage with “Ecstasy ” use in a young adult. Neurol Sci. 2002;23:199–201
  2. Beckmann YY, Seçkin M, Manavgat AI, Zorlu N. Headaches related to psychoactive substance use. Clin Neurol Neurosurg. 2012;1-10. [Ep ub ahead of p rint] 3. Boes CJ, Cap obianco DJ, Cutrer FM, Dodick D W, Eross EJ, Swanson J W. Headache and other craniof acial p ain. In:Bradley WG. Neurology in clinical p ractice: The neurological disorders.Vol 2. Philadelp hia:Butterworth-Heinemann, 2004;2055- 2056
  3. Chitwood DD. Patterns and consequences of cocaine use. NIDA Res Monogr. 1985;61:111-29
  4. Chong SC, Chan YH, Ong HT, Low PS, Tay SK. Headache diagnosis, disability and co-morbidities in a multi-ethnic, heterogeneous p aediatric Asian p op ulation. Cep halalgia. 2010;30(8):953-61. Ep ub 2010 Mar 12
  5. De Marinis M, Janiri L, Agnoli A. Headache in the use and withdrawal of op iates and other associated substances of use. Headache. 1991;31:159–63
  6. Diener HC, Tf elt-Hansen P. Headache associated with chronic use of substances. In: Tf elt-Hansen P, Welch KMA, Olesen J, editors. The Headaches. New York: Raven Press, Ltd; 1993
  7. El-Mallakh RS. Marij uana and migraine. Headache. 1987;27(8):442-3
  8. Ertas M, Baykan B, Kocasoy Orhan E, Zarif oglu M, Karli N, Saip S, Onal AE, Siva A. One-year p revalence and the imp act of migraine and tension- typ e headache in Turkey: a nationwide home-based study in adults. J Headache Pain. 2012 Mar;13(2):147-57. Ep ub 2012 Jan 14
  9. Ghodse H. Drugs of Abuse and Dep endence. In: Ghodse H, Editor. Drug and Addictive Behaviour. Cambridge University p ress, 3rd edition 2002:95- 130
  10. Goadsby PJ. Pathop hysiology of Migraine. Neurol Clin 2009;27:335–360
  11. Gossop M. Withdrawal and Detoxif ication. N. Gossop M, Editor; Drug Addiction and its Treatment. Oxf ord, Oxf ord University Press 2003:115-136
  12. Headache Classif ication Subcommittee of the International Headache Society. The International Classif ication of Headache Disorders, 2nd ed., Cep halalgia 24 (Supp ly 1); 2004:9-160
  13. Johnson RA, Gerstein DR. Initiation of use of alcohol, cigarettes, marij uana, cocaine, and other substances in US birth cohorts since 1919. Am J Public Health. 1998;88(1):27-33
  14. Levine SR, Washington JM, Moen M, Kieran SN, Junger S, Welch KM. Crack-associated stroke. Neurology. 1987;37(6):1092-3
  15. Lip ton RB, Choy-Kwong M, Solomon S. Headaches in hosp italized cocaine users. Headache.